Skip to main content
. Author manuscript; available in PMC: 2016 Aug 4.
Published in final edited form as: Future Med Chem. 2012 May;4(7):915–925. doi: 10.4155/fmc.12.51

Table 1.

Receptor for advanced glycation end products main ligands and their functions.

Ligand Ligand family Ligand-binding region Function Related disease
Advanced glycation end products AGEs V-type Advanced glycation endproducts are present in high levels in diabetes Diabetes
HMGB1 HMGB1 V-type Involved in cell stress mechanisms. It also induces cellular migration Tumor outgrowth
S100b S100 calgranulins V-type Calcium-binding protein that is related to Alzheimer's disease Alzheimer's disease
S100A6 S100 calgranulins C2-type Calcium-binding protein that binds to a different domain Alzheimer's disease
Aβ/oligomer – V-type Aggregate – C1 type Oligomer species appears more pathogenic. Aβ transport at the blood–brain barrier, cerebral blood flow reduction and neuroinflammation Alzheimer's disease
Mac-1 β2-integrin VC1 subunit Involved with leukocyte recruitment relevant in inflammatory disorders Diabetes
Transthyretin Transthyretin VC1 subunit Associated with extracellular amyloid deposits that lead to degeneration of neurons in the peripheral nerve Alzheimer's disease
LPS LPS VC1 subunit A bioactive component of bacterial cell walls, it can bind with RAGE to regulate inflammatory responses LPS-induced septic shock
Phosphatidylserine Phospholipid Bind on soluble RAGE Assists in the clearance of apoptotic cells Diabetes and atherosclerosis

Aβ: Amyloid-β; LPS: Lipopolysaccaride; RAGE: Receptor for advanced glycation end products.

HHS Vulnerability Disclosure